| Primary information |
|---|
| ID | antitb_1270, |
| Name | 26150422 |
| N-Terminal modification | VapC30 (48-56) |
| C-Terminal Modification | RFGEPGGRE |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 9 |
| Source | L |
| Species | Protein Derived |
| Strain | From VapC30 toxin |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis (strain H37Rv) |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | None |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | By disrupting the toxin-antitoxin complex (VapBC) |
| Other activities | VapBC |
| PMID | None |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |